Skip to main content

Animations

MJFF Publications

5251 - 5260 of 6284 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2024
  • 2025
  • 2025
  • 2025
  • 2023
  • 2024
  • 2023
  • Summary Details
    OPEN
    Title: Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105567
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson´s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00881-9
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Self-supervised identification and elimination of harmful datasets in distributed machine learning for medical image analysis
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41746-025-01499-0
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Arrayed CRISPR libraries for the genome-wide activation, deletion and silencing of human protein-coding genes
    Journal Name: Nature Biomedical Engineering
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41551-024-01278-4
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Functionally active modulators targeting the LRRK2 WD40 repeat domain identified by FRASE-bot in CACHE Challenge #1
    Journal Name: Chemical Science
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1039/d4sc07532c
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Domain‐Specific Prediction of Clinical Progression in Parkinson's Disease Using the Mosaic Approach
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.70289
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Temporal Trends in Hippocampal Sclerosis Surgery: An Observational Study From a Tertiary Epilepsy Centre
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.70041
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE‐PD Open‐Label Extension Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29685
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Dopaminergic PET to SPECT domain adaptation: a cycle GAN translation approach
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-024-06961-x
    Citation Count: 4
  • Summary Details
    OPEN
    Title: DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102414
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.